Physician profile
Corrin Krieg
NPI 1740859206
$2,407.48
in general payments reported to CMS, 2019-2025
11 companies · $18.81 in 2025
The $18.81 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $251 · 2022: $622 · 2023: $1,516 · 2025: $18.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,190 · Food and Beverage: $345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,189.58 |
| Food and Beverage | $344.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,762.13 | 2022-2025 | Air Optix, Dailies Aqua Comfort Plus, Dailies Total1 Multifocal |
| Johnson & Johnson Vision Care, INC. | $175.30 | 2022-2023 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $136.70 | 2021 | |
| Mallinckrodt Hospital Products INC. | $92.08 | 2021-2022 | |
| Kala Pharmaceuticals, INC. | $50.93 | 2021 | |
| Allergan, INC. | $49.16 | 2022 | |
| Bausch & Lomb Americas INC. | $45.70 | 2022-2023 | |
| Carl Zeiss Meditec USA, INC. | $34.41 | 2021 | |
| Coopervision INC. | $31.83 | 2022-2023 | Myday Contact Lens |
| Oyster Point Pharma, INC. | $29.24 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corrin Krieg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.